Opko Health (OPK.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Oct30

Analysts Petusky and H.C. Wainwright Maintain Strong Buy Ratings for Opko Health

12:12

Oct29

Opko Health released FY2025 9 Months Earnings on October 29 After-Market EST, actual revenue USD 458.43 M, actual EPS USD -0.2612

23:00

Opko Health released FY2025 Q3 earnings on October 29 After-Market EST, actual revenue USD 151.67 M (forecast USD 162.54 M), actual EPS USD 0.0278 (forecast USD -0.045)

23:00

OPKO HEALTH's MODEX Enters into Research Collaboration with REGENERON for Multispecific Antibodies

12:59

Oct22

Opko Health to Release FY2025 Q3 Earnings on October 29 After-Market EST, Forecast Revenue USD 165.74 M, EPS USD -0.045

00:05

Aug7

OPKO Health Reports $148.4M Net Loss in Q2 2025

12:33

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 151.67 M, Net Income 21.63 M, EPS 0.0278

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 156.81 M, Net Income -148.44 M, EPS -0.1883

Apr30

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 149.95 M, Net Income -67.61 M, EPS -0.1006

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change